26
Participants
Start Date
May 20, 2021
Primary Completion Date
December 9, 2021
Study Completion Date
December 9, 2021
Cannabidiol (CBD) powder formulation
T-P-S-10 Caliper powder - 30 mg CBD in the form of 300 mg of 10% CBD isolate (Formulation 725: Water soluble.Contains sorbitol)
Cannabidiol (CBD) Oil based tincture formulation
30 mg CBD isolate in MCT oil,1:1 ratio of CBD to Medium Chain Triglycerides oil. (Formulation 088: Not water soluble. Contains medium chain triglyceride coconut oil.)
Cannabidiol (CBD) Gum Arabic, maltodextrin base formulation
10% CBD Gum Arabic, maltodextrin base(Formulation 126: Water soluble. Contains gum arabic and maltodextrin)
Cannabidiol (CBD) Gum Arabic, sorbitol base formulation
10% CBD Gum Arabic, sorbitol base (Formulation 213: Water soluble. Contains gum arabic and sorbitol)
Cannabidiol (CBD) Isolate in water formulation
Pure CBD as crystalline powder (\>99% purity) (Formulation 625 Not water soluble)
CBD matching Placebo
Matching Placebo
Colorado State University, Dept. of Health and Exercise Science, Fort Collins
Colorado State University
OTHER